INSIGHTS

On 2 nd December 2025, the Delhi High Court declined to grant an interim injunction restraining Dr. Reddy’s Laboratories from manufacturing semaglutide in India for export, notwithstanding Novo Nordisk’s assertion of infringement of Indian patent IN 262697 (IN’697). The Court’s order, rendered at the interlocutory stage, did not adjudicate the final validity of the patent but turned on the application of settled principles governing interim relief under Indian patent law. Th

Indian patent law has shown increased interest in "auxiliary claims" throughout the last few years. Auxiliary claims provide an...

Understanding Form 27 Form 27 is a very important document in the Indian patent system, through which details regarding the commercial...

Patent pooling is a form of arrangement by which entities can bring in the rights associated with a patented invention to interdependent...